Further, we identified that aberrantly high expression levels of IDO1 related to tryptophan metabolic abnormalities in tumor cells could release L-kyn enriched EVs, contributing to increased NAD + levels of endothelial cells, which might be involved in mitophagy activation. The gene discussed is IDO1; the disease is neoplasm.